FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for a bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride product (NDA 050786) from H2-Pharma, LLC. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth Subcitrate Potassium (bismuth subcitrate potassium)
• METRONIDAZOLE (Metronidazole)
• Tetracycline Hydrochloride (tetracycline hydrochloride)

Snippet

SUPPL AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)